But seeking prior authorization has become an increasing burden recently for neurologists because of an explosion of new, effective drugs with stratospheric price tags. For Jonathan Santoro, MD, a pediatric neurologist who specializes in neuroimmunology, the obstacle-filled “game” of gaining insurance company prior authorization is a constant frustration. “The dam is about to burst when it comes to prior authorization, because everyone's talking about it,” Dr. Nair said. More than 60 percent said they had to start with less-effective medications and that prior authorization had led to extra office visits. Doctors who achieved a 90 percent acceptance rate in the previous year would be exempt from prior authorization for a year.

Source: Washington Post January 04, 2024 05:06 UTC